from Reuters: Health News https://reut.rs/2Go2ZQs
Tuesday, February 12, 2019
Clinigen buys U.S. rights to Novartis' cancer drug Proleukin
British pharmaceutical firm Clinigen Group Plc said on Wednesday it acquired the U.S. rights to Swiss drugmaker Novartis AG's skin and lung cancer drug Proleukin for a total of $210 million, including some future payments.
from Reuters: Health News https://reut.rs/2Go2ZQs
from Reuters: Health News https://reut.rs/2Go2ZQs
Subscribe to:
Post Comments (Atom)
-
(Reuters Health) - More than half of heart failure patients who visit the emergency room don't receive prompt follow-up care, and a Cana...
-
WEIGHT LOSS supplements could help overweight or obese patients with the diet plans. You could lose weight and avoid weight gain by adding...
-
A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for an temporary restraining order blocking sales of generic v...
No comments:
Post a Comment